Singular Health Group Limited welcomed the official appointment of Mr. Denning Chong as Chief Executive Officer. Following his appointment as Interim CEO and Managing Director in April 2023: Resignation of Managing Director and Strategic Review, dated 17th April 2023), Mr. Chong has been instrumental in leading a strategic review that has seen the consolidation of premises and streamlining of the Group's structure to reduce operating costs, and a strong focus on enterprise-led sales of the 3Dicom software. As a co-founder of Singular Health and previous Non-Executive Director of Singular Health, Mr. Chong has a strong knowledge of the medical technology landscape, the Company's operations and the support of the team and significant shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 AUD | -.--% | -.--% | +176.32% |
15/05 | Singular Health Boosts Balance Sheet with Follow-On Marin and Sons Investment | MT |
28/02 | Singular Health Group Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+176.32% | 1.36Cr | |
-9.49% | 2.82TCr | |
+25.35% | 832.85Cr | |
+33.25% | 439.32Cr | |
-35.85% | 243Cr | |
-9.44% | 160.35Cr | |
-13.39% | 149.66Cr | |
-32.84% | 114.66Cr | |
+7.80% | 96Cr | |
-37.56% | 87Cr |
- Stock Market
- Equities
- SHG Stock
- News Singular Health Group Ltd
- Singular Health Group Limited Announces Appointment of Mr. Denning Chong as Chief Executive Officer